FIELD: chemistry.
SUBSTANCE: invention relates to the field of organic chemistry, namely to hydrobromide 4'- (2,3-dihydro-9H-imidazo[1,2-a]benzimidazol-9-yl-methyl)biphenyl-2-carbonitrile of formula I.
.
EFFECT: new compound is obtained in the series of derivatives 2,3-dihydroimidazo[1,2-a]benzimidazole, exhibiting the properties of the AMPK activator.
1 cl, 1 dwg, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIDIABETIC REMEDY | 2017 |
|
RU2657832C1 |
9-BENZYL-2-BIPHENYLIMIDAZO[1,2-A]BENZIMIDAZOLE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF THAT EXPRESS PROPERTIES OF DESTROYERS OF TRANSVERSAL CROSS-LINKS OF GLYCOSYLATED PROTEINS | 2016 |
|
RU2627769C1 |
9-SUBSTITUTED-2-BIPHENYLIMIDAZO[1,2-A]BENZIMIDAZOLES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, HAVING ANTIOXIDANT AND ANTIRADICAL PROPERTIES | 2017 |
|
RU2649979C1 |
APPLICATION OF THIENOPYRIDONE DERIVATIVES AS AMPA-ACTIVATORS AND PHARMACEUTIC COMPOSITIONS, CONTAINING THEM | 2006 |
|
RU2416409C2 |
PHARMACEUTICAL COMPOSITION OF ANTITHROMBOTIC ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696869C1 |
1-(3-MORPHOLINOPROPYL)-2-PHENYLIMIDAZO[1,2-a]-BENZIMIDAZOLE DIHYDROCHLORIDE, HAVING PURINE P2Y-RECEPTOR ANTAGONIST PROPERTIES, ANTIAGGREGANT AND ANTITHROMBOTIC ACTIVITY | 2008 |
|
RU2391345C2 |
GEROPROTECTOR FOR MODEL ANIMALS | 2016 |
|
RU2639500C1 |
9-ω-ARYLOXYALKYL-2,3-DIHYDROIMIDAZO[1,2-A]-BENZIMIDAZOLE SALTS ELICITING TOPICALLY ANESTHETIC EFFECT | 2003 |
|
RU2233279C1 |
PHARMACEUTICAL COMPOSITION OF ANTIMIGRAINE ACTION IN SOLID DOSAGE FORM IN THE FORM OF TABLETS | 2019 |
|
RU2696866C1 |
11-(4-TERT-BUTYLBENZYL)-2,3,4,5-TETRAHYDRO[1,3]DYAZEPINO[1,2-A]BENZIMIDAZOLE HYDROBROMIDE WITH ANXIOLYTIC AND ANTICONVULSANT ACTIVITY | 2017 |
|
RU2662242C1 |
Authors
Dates
2018-04-18—Published
2017-10-23—Filed